๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Advanced Hepatocellular Carcinoma

Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC NCT06553885Phase 21 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Enfortumab Vedotin Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Shanghai GV20 Therapeutics ยท Tests: GV20-0251 Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma NCT05954897Phase 21 site๐Ÿ“ Guangzhou Guangdong Provincial People's Hospital ยท Tests: Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT) NCT07312292Phase 21 site๐Ÿ“ Utrecht Niek Wijnen ยท Tests: Angiotensin II (Giaprezaยฎ), Yttrium-90 radioembolization Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC NCT06041477Phase 31 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU, Concurrent Lenvatinib, Concurrent PD-1 antibody, Sequential Lโ€ฆ Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein ฮฒ-Catenin, The SAPHIRE Trial NCT06811116Phase 1, Phase 24 sites๐Ÿ“ Irvine๐Ÿ“ Orange๐Ÿ“ Portland National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Cabozantinib S-malate, Imaging Procedure, Sapanisertib Combination of TATE and PD-1 Inhibitor in Liver Cancer NCT03259867Phase 23 sites๐Ÿ“ Orange๐Ÿ“ Oklahoma City๐Ÿ“ Milwaukee Teclison Ltd. ยท Tests: Nivolumab Injectable Product, Trans-arterial tirapazamine embolization A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Lake Mary๐Ÿ“ Lebanon 7 Hills Pharma, LLC ยท Tests: Alintegimod, Ipilimumab, Nivolumab PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma NCT07018518Phase 11 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: PIN +anti-PD1 Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment NCT06374485Phase 11 site๐Ÿ“ Hong Kong Lee's Pharmaceutical Limited ยท Tests: AU409 Atezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical Trial NCT05751343Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: TACE-HACI, plus atezolizumab-bevacizumab JMT106 Injection in the Treatment of Advanced Solid Tumors NCT07275073Phase 11 site๐Ÿ“ Zhejiang Shanghai JMT-Bio Inc. ยท Tests: JMT106 Injection Mts105 for Advanced Hepatocellular Carcinoma NCT06689540Phase 11 site๐Ÿ“ Beijing Shen Lin ยท Tests: MTS105 Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma NCT07536789Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: MRG003 A Study of VRT106, Combined With Camrelizumab, and Apatinib for Advanced HCC NCT07589244Phase 2, Phase 31 site๐Ÿ“ Guangzhou Guangzhou Virotech Pharmaceutical Co., Ltd. ยท Tests: VRT106, VRT106 in combination with camrelizumab and apatinib, Investigator's Choice of Standard of Care An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma NCT07493044Phase 11 site๐Ÿ“ Guangzhou Guangzhou FineImmune Biotechnology Co., LTD. ยท Tests: Super CAR-T Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis NCT06166576Phase 25 sites๐Ÿ“ Ilsan๐Ÿ“ Seongnam-si๐Ÿ“ Seoul Seoul National University Hospital ยท Tests: Ablative radioembolization HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC NCT06632093n/a1 site๐Ÿ“ Shenyang First Hospital of China Medical University ยท Tests: hepatic artery infusion chemotherapy, Lenvatinib + PD-1 monoclonal antibody A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer NCT06636435Phase 15 sites๐Ÿ“ Kashiwa๐Ÿ“ Yokohama๐Ÿ“ Niigata Chiome Bioscience Inc. ยท Tests: CBA-1205 Part 1, CBA-1205 Part 2, CBA-1205 Part 3, CBA-1205 Part 4, CBA-1205 Part 5 A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma NCT05440708Phase 1, Phase 221 sites๐Ÿ“ Birmingham๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Tvardi Therapeutics, Incorporated ยท Tests: TTI-101, Pembrolizumab, Atezolizumab, Bevacizumab Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors NCT04803318Phase 21 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: Combination of three inhibitors Trametinib, Everolimus and Lenvatinib Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies NCT03539822Phase 1, Phase 22 sites๐Ÿ“ Westwood๐Ÿ“ Pittsburgh Anwaar Saeed ยท Tests: Cabozantinib, Durvalumab, Tremelimumab Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC NCT05652920Phase 1, Phase 27 sites๐Ÿ“ Beijing๐Ÿ“ Changsha๐Ÿ“ Changchun OriCell Therapeutics Co., Ltd. ยท Tests: Ori-C101 PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma. NCT07053072Phase 12 sites๐Ÿ“ Chengdu๐Ÿ“ Chengdu West China Hospital ยท Tests: Low Dose PD-1 mRNA LNP Vaccine, High dose PD-1 mRNA LNP vaccines Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer NCT05323201Phase 1, Phase 21 site๐Ÿ“ Xuzhou The Affiliated Hospital of Xuzhou Medical University ยท Tests: fhB7H3.CAR-Ts, Fludarabine, Cyclophosphamide Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma NCT03949231Phase 31 site๐Ÿ“ Guanzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: PD1/PDL1 inhibitor Identification of an Immune Single Cell Transcriptomic Profile of Responder and Non-responder Hepatocellular Carcinoma Patients Treated With Immune-checkpoint Inhibitors NCT07273708n/a1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial NCT07166406Phase 3139 sites๐Ÿ“ Berkeley๐Ÿ“ Cameron Park๐Ÿ“ Fremont NRG Oncology ยท Tests: Atezolizumab, Bevacizumab, Biospecimen Collection, Computed Tomography, Durvalumab Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study NCT06301399Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Rituximab+PD-1 or PD-L1 inhibitors+targeted therapy Peg IFNฮฑ-2b Therapy for Unresectable Mid to Late Stage HBV-HCC NCT07769827NA1 site๐Ÿ“ Nanjing Jinling Hospital, China ยท Tests: Combined Peg IFNฮฑ-2b treatment group
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy